Drugs / PR022
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03351777 | Dec 2017 → Apr 2018 | atopic eczema | Realm Therapeutics, Inc. | Unknown | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PR022 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03351777 ↗ |
| Route | Topical | “Topical Gel” NCT03351777 ↗ |